Table 3:
Recurrence Rates in Randomized Controlled Trials
| Author, Year | Recurrence Rate | P |
|---|---|---|
| Kapp et al, 201326 |
6 months leg locationa 23–32 mm Hg: 7/49 (14.3%) 34–46 mm Hg: 6/44 (13.6%) |
1.00 |
|
6 months study ulcera 23–32 mm Hg: 7/49 (14.3%) 34–46 mm Hg: 4/44 (9.1%) |
.65 | |
| Clarke-Moloney et al, 201425 |
12 months 18–21 mm Hg: 10/50 (20%) 23–32 mm Hg: 6/50 (12%) |
.29 |
| For those adhered to MCS: 9/85 (10.6%) 18–21 mm Hg: 6/43 (14%) 23–32 mm Hg: 3/45 (7%) |
.31 | |
| For those not adhered to MCS: 7/11 (63.6%) Risk ratio: 6.2 (95% CI, 2.9–13.5; P < .001) |
||
| Nelson et al, 200627 |
5 years 18–24 mm Hg: 59/151 (39%) 25–35 mm Hg: 48/149 (32%) |
.13 |
| Vandongen & Stacey, 200028 |
6 months MCS: 15/72 (21%) No MCS: 37/81 (46%) 12 months MCS: 17/72 (24%) No MCS: 44/81 (54%) Median percentage change in lipodermatosclerosis area in participants who did not develop ulcers 12 months (n = 46) MCS: −33.1 (95% CI, −61.9–15.07) No MCS: +11.9 (95% CI, −24.6–122.2) |
.04 |
Abbreviation: MCS, medical compression stocking.
a
Study ulcers develop in the same anatomical location as the previous ulcer. Leg location ulcers develop in a different anatomical location as the previous ulcer.